Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Sale
+$638,891
-22.04%
Shares
Shares Volume: 20,961 Shares
Average Share Price: $30.48
INSIDER
Yale Catriona
Chief Development Officer (Officer)
reported on Oct 16 2024
traded on Oct 14 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 74,158 |
| PURCHASES/SALES 1Y | 0 / 9 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $251,617.31 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 2 / 36 |
| P/S VALUE RATIO | 0.237 |
| AVERAGE SALE VALUE | $430,910.82 |
| COMPANY PREVIOUS TRADES |